<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Commercialise and partner successfully in Europe a...

Understand how to commercialise via partnering in Europe and other markets ...

Read More

Brexit: finite uncertainty

One might think that planning for uncertainty is something that biotech fir...

Read More

In a new age of personalised cancer therapy, is pa...

On 5 September 2018 it was announced that the NHS has struck a deal with No...

Read More

Make Brexit a non-issue for pharma

What is the recipe for keeping business momentum in clinical trials despite...

Read More

Technical notices for a ‘no-deal’ Brexit

The UK government issued a series of ‘technical notices’ on 23 August outli...

Read More

Experimental data in a European patent application...

It is not unusual for an inventor or applicant to ask: “How much experiment...

Read More

A Valuation Expert’s Viewpoint: Life Science Chall...

The Nordic region, as one of the hubs of the life science sector in Europe,...

Read More

Investorview: Ingredients for growth in life scien...

Industrifonden is an evergreen venture capital fund with headquarters in St...

Read More

Does Brexit affect your European patent strategy?

The process of obtaining patent protection in Europe is unaffected by Brexi...

Read More

Inceptua: Partnering with life sciences companies ...

Key learnings: Inceptua Group’s expanded breadth of capabilities across cli...

Read More

Building a thriving life sciences hub in the Nordi...

On Thursday 30 August, an expert panel will take to the stage at the inaugu...

Read More

Unlocking Potential in the Nordic Life Sciences Se...

In 2017, life science companies in Scandinavia raised almost $2.2 billion t...

Read More

Add Your Response